Preliminary Study of Piclozotan in Patients With Motor Complications Associated With Parkinson's Disease

Trial Profile

Preliminary Study of Piclozotan in Patients With Motor Complications Associated With Parkinson's Disease

Completed
Phase of Trial: Phase II

Latest Information Update: 16 Aug 2017

At a glance

  • Drugs Piclozotan (Primary)
  • Indications Drug-induced dyskinesia; Parkinson's disease
  • Focus Therapeutic Use
  • Sponsors Daiichi Sankyo Inc
  • Most Recent Events

    • 27 May 2009 Actual patient number (27) added as reported by ClinicalTrials.gov.
    • 27 May 2009 Additional locations identified as reported by ClinicalTrials.gov.
    • 13 Jul 2008 The expected completion date for this trial is extended from Mar 2008 to Jul 2008 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top